Danish devices association urges authorities to deter reuse firm
This article was originally published in Clinica
Denmark's state serum institute (SSI) has denied suggestions that it has in any way approved the practices of German medical devices reprocessing company Vanguard. This statement comes despite the publication of a report by SSI in which it claims that the resterilisation of single-use devices is defensible "in certain cases". In reply to a letter from Medicoidustrien, the medical devices industry association, SSI said that it did not even have the authority to approve such procedures.
You may also be interested in...
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.